乳癌治疗actuuzumab govitecan 显示有望在未来的试验中治疗脑肿瘤。 Breast cancer treatment sacituzumab govitecan shows promise in treating brain tumors in a prospective trial.

德克萨斯大学圣安东尼奥健康科学中心的一项研究发现, 乳腺癌治疗的有效药物萨基图祖马布戈维特肯 (sacituzumab govitecan) 对于治疗由该疾病引起的脑瘤有望. A University of Texas Health Science Center San Antonio study finds that sacituzumab govitecan, an effective breast cancer treatment, shows promise in treating brain tumors that arise from the disease. 在预期的试验中,病人在手术前就接受了这种药物,研究人员发现,对于患乳腺癌的人来说,这种药物在进入脑肿瘤之前就已经很好地发放并有效。 In a prospective trial, patients received the drug before surgery, and researchers found it to be well-tolerated and effective for those with breast cancer progressing to brain tumors. 这可以为患三联负性乳腺癌的妇女提供新的治疗,因为一半的妇女有脑部转移和预测不良。 This could offer a new therapy for women with aggressive triple-negative breast cancer, where half have brain metastases and a poor prognosis.